Showing results (51-60 of 154) with videos related to
Sort By:
Pageof 16
Deutsche Medizinische Wochenschrift (1946)|June 4, 2014
[Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy]U Nowak-Göttl, F Langer, V Limperger, et al.Medical and Pediatric Oncology|August 1, 1995
Acquired von Willebrand disease in malignant peripheral neuroectodermal tumor (PNET)U Nowak-Göttl, B Kehrel, U Budde, et al.Klinische Padiatrie|June 11, 2010
Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and childrenN Schlegel, V Bardet, G Kenet, et al.Thrombosis Research|March 15, 1996
APC resistance in neonates and infants: adjustment of the APTT-based methodU Nowak-Göttl, B Kohlhase, H Vielhaber, et al.Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
Role of elevated alpha2-macroglobulin revisited: results of a case-control study in children with symptomatic thromboembolismA Beheiri, C Langer, C Düring, et al.European Journal of Pediatrics|January 29, 2000
Role of genetic prothrombotic risk factors in childhood caval vein thrombosisN Münchow, A Kosch, R Schobess, et al.Stroke|November 3, 2001
Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up studyR Sträter, K Kurnik, C Heller, et al.European Journal of Pediatrics|February 1, 2000
Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcomeA Bökenkamp, R von Kries, U Nowak-Göttl, et al.European Journal of Pediatrics|January 29, 2000
Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutationR Schobess, R Junker, K Auberger, et al.European Journal of Pediatrics|January 29, 2000
Post-trauma coagulation and fibrinolysis in children suffering from severe cerebro-cranial traumaS Becker, W Schneider, W Kreuz, et al.Pageof 16